Suppression of Ca2+ signals by EGR4 controls Th1 differentiation and anti-cancer immunity in vivo

Jayati Mookerjee-Basu, Robert Hooper, Scott Gross, Bryant Schultz, Christina K. Go, Elsie Samakai, Jonathan Ladner, Emmanuelle Nicolas, Dietmar J. Kappes, Yuanyuan Tian, Bo Zhou, M. Raza Zaidi, Warren G. Tourtellotte, Shan He, Yi Zhang, Dietmar J. Kappes, Jonathan Soboloff

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Abstract

While the zinc finger transcription factors EGR1, EGR2, and EGR3 are recognized as critical for T-cell function, the role of EGR4 remains unstudied. Here, we show that EGR4 is rapidly upregulated upon TCR engagement, serving as a critical “brake” on T-cell activation. Hence, TCR engagement of EGR4−/− T cells leads to enhanced Ca2+ responses, driving sustained NFAT activation and hyperproliferation. This causes profound increases in IFNγ production under resting and diverse polarizing conditions that could be reversed by pharmacological attenuation of Ca2+ entry. Finally, an in vivo melanoma lung colonization assay reveals enhanced anti-tumor immunity in EGR4−/− mice, attributable to Th1 bias, Treg loss, and increased CTL generation in the tumor microenvironment. Overall, these observations reveal for the first time that EGR4 is a key regulator of T-cell differentiation and function.

Original languageEnglish
Article numbere48904
Pages (from-to)e48904
JournalEMBO Reports
Volume21
Issue number5
DOIs
StatePublished - May 6 2020

Keywords

  • Animals
  • Calcium Signaling
  • Cell Differentiation
  • Early Growth Response Transcription Factors
  • Lymphocyte Activation
  • Mice
  • Neoplasms
  • Tumor Microenvironment
  • Zinc Fingers

Fingerprint

Dive into the research topics of 'Suppression of Ca2+ signals by EGR4 controls Th1 differentiation and anti-cancer immunity in vivo'. Together they form a unique fingerprint.

Cite this